Aflac stock (US0010551028): Moody's assigns A3 rating to senior notes

Aflac Incorporated received an A3 rating with a stable outlook from Moody's Investors Service on its senior unsecured notes issued on May 11, 2026, according to ad-hoc-news.de as of May 11, 2026. This rating underscores the company's solid financial standing amid its operations in supplemental health and life insurance. The development signals Moody's view of Aflac's ability to meet debt obligations.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

Aflac: core business model

Aflac Incorporated specializes in supplemental insurance products, primarily covering health and life risks not typically included in basic employer-provided plans. The company operates predominantly in the United States and Japan, where it holds significant market share in voluntary insurance. Aflac's model relies on payroll deductions and direct marketing to distribute policies, generating steady premium revenue.

This focus on supplemental coverage positions Aflac as a key player for US investors seeking exposure to the insurance sector, particularly products that address gaps in traditional health insurance amid rising medical costs.

Main revenue and product drivers for Aflac

Aflac derives the majority of its revenue from premiums on cancer, accident, hospital indemnity, and critical illness policies. In the US, cancer insurance remains a flagship product, while Japan contributes through whole life and medical insurance lines. For the quarter ended March 31, 2026, revenue details will be detailed in upcoming reports.

Investment income from the portfolio of fixed-income securities also supports earnings, providing stability. The NYSE-listed stock (AFL) traded at $103.37 on July 25, 2025, on NYSE, according to StockInvest.us as of Jul 25, 2025.

Industry trends and competitive position

The supplemental insurance market in the US continues to grow due to increasing healthcare deductibles and out-of-pocket expenses. Aflac maintains a competitive edge through brand recognition, particularly its Aflac Duck campaign, and a distribution network exceeding 200,000 brokers. In Japan, it faces competition from domestic insurers but benefits from high penetration of supplemental products.

Why Aflac matters for US investors

Aflac offers US investors diversified geographic exposure, with roughly half its revenue from Japan, hedging against pure domestic economic cycles. Its NYSE listing and consistent dividend history appeal to income-focused portfolios. The recent Moody's rating enhances its attractiveness in a sector sensitive to credit perceptions.

Conclusion

The Moody's A3 rating assignment to Aflac's senior notes highlights ongoing confidence in its creditworthiness as of May 11, 2026. Combined with its established position in supplemental insurance across the US and Japan, the company remains a notable name in the sector. Investors will watch upcoming earnings and market developments for further insights.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.